: Increasing Awareness About The Functional Benefits of Health Supplements is Expected to Boost The Market Growth During The Forecast Period, 2017-2023

Pune, India, December, 2017 /MRFR Press Release/- Market Research Future has a half cooked research report on the global health supplements market.

Market Highlights

Cardiovascular diseases affects a large percentage of the world's population. The number of patients promoting the use of health supplements for reducing the risk of cardiovascular diseases have been increasing. Health supplement as the name suggests are also used as an alternative for getting vital substances which help the body to perform effectively. However, it should not be used to replace the regular meals which are necessary for a healthy diet.

According to the Centers for Disease Control and Prevention, in 2015, out of the 17 million premature deaths before the age of 70 caused due to non-communicable diseases, 37% are due to CVDs.

Increasing prevalence of rheumatic disorders, cardiovascular diseases, and allergy in the population is boosting the demand of health supplement products globally. Additionally rising awareness about the functional benefits of health supplements, increasing urbanization and changing lifestyles, increasing investments in biotechnology and pharmaceutical industries for research and development, and availability of funds are fuelling the growth of this market. Moreover, increase in government support for research & development and rapid development in quality of drugs is expected to fuel the market growth during the forecast period.

The global health supplements market is expected to grow at a CAGR of 7.8% during the forecast period 2017-2023.

Regional Analysis

The Americas dominate the global health supplements market owing to the presence of huge patient pool with cardiovascular diseases. Furthermore high healthcare spending, and increasing government support for research & development is fuelling the market growth. According to the Centers for Disease Control and Prevention (CDC), in 2015, around 17.7 million people died from CVD, which represents 31% of all global deaths, of these deaths around 7.4 million were due to coronary heart disease and 6.7 million were due to stroke.

Europe holds the second largest share of the global health supplements market as result of increasing focus of various government and private agencies on the treatment of CVD, rheumatic disorders, and allergy. Moreover, the growing public awareness about health supplements is likely to boost the European market.

Asia Pacific is the fastest growing health supplements market across the globe. Moreover, rapidly developing economy and market players focusing to capture maximum market share for maximizing their profit is projected to drive the market in this region over the forecasted period.

The Middle East and Africa holds the least share of the global market due to lack of awareness about health supplements and least focus of market players.

Segmentation

The global health supplements market is segmented on the basis of types, by application, and by end user. On the basis of the type, it is segmented into hormone, Erythropoietin, Monoclonal antibodies, Interferon, Calcitonin, and others. On the basis of the application, it is segmented into cancer, blood disorders, chronic diseases, infectious diseases, and others. On the basis of the end user, it is segmented into hospitals, clinics, and research centers.

Key Players

Some of key the players in the market are Astellas Pharma Inc. (Japan), Sanofi S.A. (France), Regeneron Pharmaceuticals, Inc. (U.S.), Valeant Pharmaceuticals International, Inc (Canada), Anacor Pharmaceuticals Inc. (U.S.), Novartis International AG (Switzerland), Bristol-Myers Squibb (U.S.), Meda Pharmaceuticals (U.S.), Pfizer Inc. (U.S.), Galderma S.A. (Switzerland), Allergan Plc. (Republic of Ireland)

Report Details @ https://www.marketresearchfuture.com/reports/health-supplements-market-1646